Form 4 Filing for Orchestra BioMed Holdings, Inc.

This Form 4 filing details a transaction by Andrew Taylor, Chief Financial Officer of Orchestra BioMed Holdings, Inc. On May 28, 2026, Mr. Taylor disposed of 3,076 shares of common stock. The disposal was a result of the withholding of shares by the Issuer to satisfy tax obligations in connection with the vesting of restricted stock units (RSUs). No shares were sold on the market. The transaction price was $3.98 per share, and following this transaction, Mr. Taylor owns 629,417 shares. The filing is labeled as a disposal of securities by an insider.